HOPA News Spring 2026 - AL Amyloidosis: When Small Proteins Cause Big Problems
Read the latest issue of HOPA News, featuring articles on AL Amyloidosis, first-line treatment for mantle cell lymphoma, mentoring the next generation of oncology pharmacists, and much more!
Click here to read more
Latest News
Oncology Pharmacist Day: Celebrating the People Who Make the Profession
On April 3, 2026, the oncology pharmacy community will mark the first-ever Oncology Pharmacist Day, a new annual observance recognizing the essential role hematology/oncology pharmacists play in improving the lives of people affected by cancer.
Late-Breaking HOPA News: Redefining Relapse: What MajesTEC-3 Means for the Treatment of Multiple Myeloma
Sanja Zepcan, PharmD, BCPS, BCOP, and Emily Rux, PharmD, BCOP, discuss the clinical questions raised by the recent MajesTEC-3 trial and the potential changes it finds in the treatment of multiple myeloma.
Pharmacist's Application to Practice: Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Cristina V. Martinez, PharmD, PGY2 Oncology Pharmacy Resident, and Hunter Sowell, PharmD, BCOP, Clinical Pharmacy Specialist Oncology, analyze the potential role for pirtobrutinib in treating chronic lymphocytic leukemia and small lymphocytic lymphoma.
Explore More from HOPA
Pharmacist's Application to Practice: Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Cristina V. Martinez, PharmD, PGY2 Oncology Pharmacy Resident, and Hunter Sowell, PharmD, BCOP, Clinical Pharmacy Specialist Oncology, analyze the potential role for pirtobrutinib in treating chronic lymphocytic leukemia and small lymphocytic lymphoma.
As 2026 Forges Ahead, A Look Back at HOPA in 2025
2025 certainly brought challenges both new and familiar to HOPA, our members, our patients, and those dear to them. But it's also brought hope. It's brought progress. And it's brought an inspiring sense of purpose, passion, and community.
What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown
On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.
Overcoming Challenges to Provide BiTE and CAR T Cell Therapy at a Community Cancer Center
Krista L. Voytilla, PharmD, BCOP, and Chase N. Ayres, PharmD, BCOP, review the technical and clinical issues facing community cancer centers and their pharmacy teams delivering these high-tech treatments.
Pharmacist's Application to Practice: Zongertinib
Reyam Katchi, PharmD, PGY2 Hematology/Oncology Pharmacy Resident, and Kiera Roubal, PharmD, Oncology Clinical Pharmacist, break down the potential role for zongertinib in the treatment of non-squamous NSCLC with HER2 TKD activating mutations.
Pharmacy Students and Oncology Pharmacists Combat Cancer Misinformation with National Initiative
The Hematology/Oncology Pharmacy Association (HOPA) is proud to team up with the Student National Pharmaceutical Association (SNPhA) for the Cancer Clarity Challenge, a new national competition.
Oncology Pharmacist Day: Celebrating the People Who Make the Profession
On April 3, 2026, the oncology pharmacy community will mark the first-ever Oncology Pharmacist Day, a new annual observance recognizing the essential role hematology/oncology pharmacists play in improving the lives of people affected by cancer.
Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages
HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.
2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
The in-person annual Transplantation & Cellular Therapy Meetings of ASTCT™ (American Society for Transplantation and Cellular Therapy) and CIBMTR® (Center for International Blood and Marrow Transplant Research) took place from February 15-19, 2023 in Orla
Pharmacist's Application to Practice: Taletrectinib
Benjamin Pastore, PharmD, PGY2 Adult Oncology Pharmacy Resident, and Jasmine Patel, PharmD, BCOP, Clinical Pharmacy Specialist - Thoracic Oncology, discuss the potential role of taletrectinib in the treatment of metastatic non-small cell lung cancer.
Work-Life Harmony Isn’t About Perfection; It’s About Priorities and Support
Striking the balance between work and family is challenging, but with the right mindset and support, it is possible. And when we succeed, we not only become better parents but also better pharmacists, leaders, and colleagues.